25.02.2025 13:37:27
|
Harmony Biosciences Holdings, Inc Q4 Profit Increases, Beats Estimates
(RTTNews) - Harmony Biosciences Holdings, Inc (HRMY) released earnings for its fourth quarter that increased from the same period last year and beat the Street estimates.
The company's bottom line totaled $49.48 million, or $0.85 per share. This compares with $26.61 million, or $0.45 per share, last year.
Excluding items, Harmony Biosciences Holdings, Inc reported adjusted earnings of $63.03 million or $1.08 per share for the period.
Analysts on average had expected the company to earn $0.82 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 19.5% to $201.27 million from $168.41 million last year.
Harmony Biosciences Holdings, Inc earnings at a glance (GAAP) :
-Earnings: $49.48 Mln. vs. $26.61 Mln. last year. -EPS: $0.85 vs. $0.45 last year. -Revenue: $201.27 Mln vs. $168.41 Mln last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Harmony Biosciencesmehr Nachrichten
24.02.25 |
Ausblick: Harmony Biosciences gewährt Anlegern Blick in die Bücher (finanzen.net) | |
28.10.24 |
Ausblick: Harmony Biosciences stellt Zahlen zum jüngsten Quartal vor (finanzen.net) |
Analysen zu Harmony Biosciencesmehr Analysen
Aktien in diesem Artikel
Harmony Biosciences | 32,18 | -4,93% |
|